Abbott Submits Marketing Authorization Application of Humira (adalimumab), a Fully Human Monoclonal anti-TNF- Antibody, for the Treatment of Ankylosing Spondylitis in Japan
Dear User, JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb
